Careers

Diversity, Equity & Inclusion

Experience

Innovation

Interactive Maps

Locations

About

Pages

Meet our team of innovators
Ask us how we do it

Professionals

Insights

Services

Thompson Hine LLP, a full-service business law firm with approximately 400 lawyers in 8 offices, was ranked number 1 in the category “Most innovative North American law firms: New working models” by The Financial Times and was 1 of 7 firms shortlisted for The American Lawyer’s inaugural Legal Services Innovation Award. The firm has been recognized by the National Law Journal as a Legal Technology Trailblazer and featured by Bloomberg for its innovative service delivery models, which drive accuracy and predictability. The firm’s commitment to innovation is embodied in Thompson Hine SmartPaTHTM – a smarter way to work – predictable, efficient and aligned with client goals. For more information, please visit ThompsonHine.com and ThompsonHine.com/SmartPaTH.

Home | Thompson Hine LLP

Atlanta

Chicago

Cincinnati

Cleveland

Columbus

Dayton

New York

Washington, D.C.

Bisphenol A (BPA) has been the subject of increased scrutiny by both consumer groups and governmental bodies in the U.S. and abroad. In some countries, legislation has been passed disallowing inclusion of BPA in products targeted for use by infants and children. Similar legislation is currently being proposed or has been passed in a number of states domestically, and the list of states considering such legislation is likely to expand going forward. This legislation raises concerns in fields such as Product Liability, Consumer Protection Law, and Governmental Regulation.

contentpilot/introduction

Consumers, through various outlets, are becoming more aware of allegedly, potentially harmful components of products they purchase, with particular attention being paid to products produced for infants and children. As consumers have increased concerns about the safety and efficacy of these products, manufacturers and distributors of these products and their components could become targets for litigation or banning legislation.

Bisphenol A (BPA) Litigation